 |
 |
 |
Objective of the Issue
The Company will not receive any proceeds from the Offer for sale; all proceeds will go to the Selling Shareholders.
IPO Details, Price, Market Lot
| Suraksha Diagnostic IPO Details | |
| IPO Open Date | 29 November 2024 |
| IPO Close Date | 3 December 2024 |
| IPO Issue Size | 1,91,89,330 Shares (Aggregating up to ₹846.25 Cr) |
| Fresh Issue | NIL |
| Offer for Sale | 1,91,89,330 Shares (Aggregating up to ₹846.25 Cr) |
| Retail Portion | Not less than 35.00% of the offer |
| NII Portion | Not less than 15.00% of the offer |
| QIB Portion | Not more than 50.00% of the offer |
| Listing At | NSE, BSE |
| Suraksha Diagnostic IPO Price | |
| Face Value | ₹2 Per Share |
| IPO Price Band | ₹420 to ₹441 Per Share |
| Employee Discount | — |
| IPO Issue Type | Book Built Issue |
| Suraksha Diagnostic IPO Market Lot For Retail Investor | |
| No. of Shares Per Lot | 34 Shares |
| Minimum Lot Size | 1 Lot (34 Shares) |
| Minimum Amount (Cut-off price) | ₹14,994 |
| Maximum Lot Size | 13 Lots (442 Shares) |
| Maximum Amount (Cut-off price) | ₹1,94,922 |
| Suraksha Diagnostic IPO Market Lot For S-HNI | |
| No. of Shares Per Lot | 34 Shares |
| Minimum Lot Size | 14 Lots (476 Shares) |
| Minimum Amount (Cut-off price) | ₹2,09,916 |
| Maximum Lot Size | 66 Lots (2,244 Shares) |
| Maximum Amount (Cut-off price) | ₹9,89,604 |
| Suraksha Diagnostic IPO Market Lot For B-HNI | |
| No. of Shares Per Lot | 34 Shares |
| Minimum Lot Size | 67 Lots (2,278 Shares) |
| Minimum Amount (Cut-off price) | ₹10,04,598 |
IPO Date, Listing Date, Allotment Date
| Suraksha Diagnostic IPO Time Table (Tentative) | |
| IPO Open Date | 29 November 2024 |
| IPO Close Date | 3 December 2024 |
| Basis of Allotment Date | 4 December 2024 |
| Initiation of Refunds | 5 December 2024 |
| Credit of Share to Demat Account | 5 December 2024 |
| IPO Listing Date | 6 December 2024 |
Financial Report
| Period Ended | Assets (₹ in Crore) |
Revenue (₹ in Crore) |
P A T (₹ in Crore) |
Net Worth (₹ in Crore) |
Borrowings (₹ in Crore) |
| 30 June 2024 | 314.20 | 61.85 | 7.67 | 187.05 | 7.57 |
| 31 March 2024 | 300.21 | 222.26 | 23.13 | 179.41 | 8.64 |
| 31 March 2023 | 281.20 | 193.69 | 6.07 | 155.93 | 14.01 |
| 31 March 2022 | 275.96 | 225.77 | 20.82 | 145.84 | 19.03 |
| Period Ended | 30 June 2024 | 31 March 2024 | 31 March 2023 | 31 March 2022 |
| Assets | 314.20 | 300.21 | 281.20 | 275.96 |
| Revenue | 61.85 | 222.26 | 193.69 | 225.77 |
| P A T | 7.67 | 23.13 | 6.07 | 20.82 |
| Net Worth | 187.05 | 179.41 | 155.93 | 145.84 |
| Borrowings | 7.57 | 8.64 | 14.01 | 19.03 |
| Amount in ₹ Corre | ||||
Company Promotor & Promotor’s Holding
The promoters of the company are Dr. Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma.
| Pre Issue Promotor Holding | 61.07% |
| Post Issue Promotor Holding |
Company Address
Suraksha Diagnostic Limited
Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327, New Town, Rajarhat Kolkata 700 156
Phone: 91 33 66059750
Email: investors@surakshanet.com
Website: https://www.surakshanet.com/
IPO Registrar, Lead Manager, Prospectus
| Suraksha Diagnostic IPO Prospectus |
|
| Suraksha Diagnostic IPO Registrar |
| Kfin Technologies Limited |
| Suraksha Diagnostic IPO Lead Manager |
|